CNBC's Meg Tirrell reports on Biogen and the company receiving FDA approval for an Alzheimer's treatment.
FDA approves Biogen's Alzheimer's drug
CNBC's Meg Tirrell reports on Biogen and the company receiving FDA approval for an Alzheimer's treatment.